Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127251702 | 12725170 | 2 | F | 20160819 | 20160926 | 20160908 | 20160930 | EXP | JP-JNJFOC-20160906574 | JANSSEN | 58.00 | YR | A | F | Y | 0.00000 | 20160930 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127251702 | 12725170 | 1 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | D | N | 0 | 45 | MG | SOLUTION FOR INJECTION | ||||||
127251702 | 12725170 | 2 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | D | N | 125261 | 45 | MG | SOLUTION FOR INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127251702 | 12725170 | 1 | Psoriasis |
127251702 | 12725170 | 2 | Psoriasis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127251702 | 12725170 | DE |
127251702 | 12725170 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127251702 | 12725170 | Cellulitis | |
127251702 | 12725170 | Septic shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127251702 | 12725170 | 1 | 20160621 | 20160621 | 0 | |
127251702 | 12725170 | 2 | 20160524 | 20160524 | 0 |